ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Ablynx’ vobarilizumab fails in lupus trial
pharmatimes
March 28, 2018Ablynx’ vobarilizumab has failed to hit targets in a mid-stage trial assessing its safety and effectiveness as a treatment for systemic lupus erythematosus (SLE).
Pharma Sources Insight January 2025
